| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phthalic Acids | 63 | 2022 | 476 | 9.590 |
Why?
|
| Environmental Pollutants | 79 | 2022 | 1265 | 7.810 |
Why?
|
| Phenols | 36 | 2021 | 514 | 5.630 |
Why?
|
| Environmental Exposure | 86 | 2021 | 4412 | 5.600 |
Why?
|
| Polychlorinated Biphenyls | 25 | 2021 | 235 | 5.360 |
Why?
|
| Parabens | 19 | 2021 | 114 | 4.870 |
Why?
|
| Infertility, Male | 29 | 2019 | 396 | 4.740 |
Why?
|
| Fertilization in Vitro | 40 | 2021 | 1292 | 4.120 |
Why?
|
| Semen | 24 | 2022 | 346 | 3.920 |
Why?
|
| Dioxins | 12 | 2021 | 92 | 3.890 |
Why?
|
| Spermatozoa | 30 | 2021 | 631 | 3.490 |
Why?
|
| Endocrine Disruptors | 21 | 2021 | 263 | 3.160 |
Why?
|
| Insecticides | 14 | 2017 | 191 | 2.620 |
Why?
|
| Flame Retardants | 13 | 2021 | 93 | 2.510 |
Why?
|
| Benzhydryl Compounds | 31 | 2021 | 941 | 2.440 |
Why?
|
| Maternal Exposure | 27 | 2021 | 1045 | 2.420 |
Why?
|
| Sperm Count | 22 | 2022 | 228 | 2.400 |
Why?
|
| Diethylhexyl Phthalate | 16 | 2021 | 83 | 2.370 |
Why?
|
| Reproductive Techniques, Assisted | 25 | 2021 | 497 | 2.360 |
Why?
|
| Sperm Motility | 22 | 2022 | 265 | 2.280 |
Why?
|
| Dibutyl Phthalate | 6 | 2019 | 29 | 2.090 |
Why?
|
| Pesticides | 13 | 2020 | 293 | 2.040 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 9 | 2015 | 85 | 1.970 |
Why?
|
| Hydrocarbons, Chlorinated | 8 | 2020 | 120 | 1.930 |
Why?
|
| Puberty | 10 | 2019 | 498 | 1.850 |
Why?
|
| Thyroid Hormones | 9 | 2020 | 403 | 1.820 |
Why?
|
| Russia | 23 | 2021 | 381 | 1.810 |
Why?
|
| Infertility | 18 | 2021 | 655 | 1.790 |
Why?
|
| Plasticizers | 10 | 2019 | 50 | 1.740 |
Why?
|
| Semen Analysis | 17 | 2022 | 234 | 1.710 |
Why?
|
| Infertility, Female | 15 | 2020 | 759 | 1.640 |
Why?
|
| Hexachlorobenzene | 7 | 2015 | 27 | 1.610 |
Why?
|
| Pregnancy Outcome | 25 | 2021 | 2907 | 1.580 |
Why?
|
| Cosmetics | 6 | 2019 | 102 | 1.560 |
Why?
|
| Fertility | 18 | 2021 | 773 | 1.560 |
Why?
|
| Pregnancy | 116 | 2022 | 29746 | 1.410 |
Why?
|
| Preservatives, Pharmaceutical | 3 | 2015 | 34 | 1.360 |
Why?
|
| Environmental Monitoring | 27 | 2021 | 1441 | 1.330 |
Why?
|
| Sexual Maturation | 5 | 2019 | 260 | 1.320 |
Why?
|
| Mesalamine | 7 | 2019 | 136 | 1.240 |
Why?
|
| Live Birth | 16 | 2021 | 512 | 1.190 |
Why?
|
| Follicular Fluid | 8 | 2021 | 92 | 1.150 |
Why?
|
| Abortion, Spontaneous | 9 | 2020 | 530 | 1.150 |
Why?
|
| Reproduction | 10 | 2021 | 646 | 1.130 |
Why?
|
| Lead | 7 | 2022 | 880 | 1.120 |
Why?
|
| Pesticide Residues | 7 | 2021 | 95 | 1.120 |
Why?
|
| Embryo Implantation | 8 | 2016 | 270 | 1.050 |
Why?
|
| DNA Damage | 11 | 2019 | 2442 | 1.010 |
Why?
|
| Halogenated Diphenyl Ethers | 10 | 2021 | 83 | 0.980 |
Why?
|
| Carbaryl | 5 | 2007 | 8 | 0.960 |
Why?
|
| Adult | 207 | 2022 | 220007 | 0.940 |
Why?
|
| Furans | 4 | 2021 | 199 | 0.940 |
Why?
|
| Paternal Exposure | 7 | 2021 | 94 | 0.930 |
Why?
|
| Follicle Stimulating Hormone | 11 | 2019 | 725 | 0.930 |
Why?
|
| Fluorocarbons | 8 | 2021 | 488 | 0.930 |
Why?
|
| Prenatal Exposure Delayed Effects | 14 | 2021 | 2496 | 0.900 |
Why?
|
| Prospective Studies | 84 | 2022 | 54306 | 0.890 |
Why?
|
| Gonadotropins, Pituitary | 2 | 2017 | 69 | 0.880 |
Why?
|
| Hazardous Substances | 3 | 2019 | 152 | 0.850 |
Why?
|
| Ovarian Follicle | 5 | 2021 | 244 | 0.840 |
Why?
|
| Quinolinic Acid | 2 | 2020 | 67 | 0.830 |
Why?
|
| Triclosan | 7 | 2019 | 58 | 0.820 |
Why?
|
| Pyrethrins | 3 | 2017 | 44 | 0.780 |
Why?
|
| Naphthols | 5 | 2014 | 46 | 0.770 |
Why?
|
| Dust | 5 | 2021 | 483 | 0.770 |
Why?
|
| Oocytes | 7 | 2020 | 1165 | 0.770 |
Why?
|
| Humans | 316 | 2022 | 760613 | 0.750 |
Why?
|
| Male | 195 | 2022 | 359718 | 0.740 |
Why?
|
| Alkanesulfonic Acids | 5 | 2021 | 199 | 0.720 |
Why?
|
| Air Pollutants | 13 | 2021 | 2844 | 0.720 |
Why?
|
| Inhibins | 8 | 2011 | 209 | 0.700 |
Why?
|
| Air Pollution, Indoor | 9 | 2021 | 893 | 0.690 |
Why?
|
| Mercury | 3 | 2021 | 290 | 0.690 |
Why?
|
| Chlorpyrifos | 4 | 2007 | 19 | 0.680 |
Why?
|
| Hair | 3 | 2017 | 497 | 0.670 |
Why?
|
| Sex Hormone-Binding Globulin | 8 | 2013 | 546 | 0.660 |
Why?
|
| Pregnancy Rate | 13 | 2020 | 649 | 0.650 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 1647 | 0.640 |
Why?
|
| Female | 198 | 2022 | 391246 | 0.630 |
Why?
|
| Linear Models | 20 | 2019 | 5877 | 0.620 |
Why?
|
| Gonadal Steroid Hormones | 5 | 2016 | 701 | 0.600 |
Why?
|
| Gonadal Hormones | 1 | 2017 | 30 | 0.600 |
Why?
|
| Body Mass Index | 22 | 2020 | 12914 | 0.590 |
Why?
|
| Comet Assay | 6 | 2008 | 74 | 0.590 |
Why?
|
| Vehicle Emissions | 3 | 2019 | 653 | 0.590 |
Why?
|
| Endocrine Glands | 1 | 2017 | 101 | 0.580 |
Why?
|
| Automobiles | 1 | 2018 | 111 | 0.580 |
Why?
|
| Product Packaging | 1 | 2017 | 24 | 0.580 |
Why?
|
| European Union | 2 | 2015 | 157 | 0.580 |
Why?
|
| Occupational Exposure | 14 | 2017 | 1809 | 0.570 |
Why?
|
| Nutrition Surveys | 8 | 2021 | 1725 | 0.570 |
Why?
|
| Leiomyoma | 5 | 2021 | 654 | 0.570 |
Why?
|
| Soy Foods | 3 | 2016 | 44 | 0.560 |
Why?
|
| Estradiol | 8 | 2020 | 1932 | 0.550 |
Why?
|
| Luteinizing Hormone | 7 | 2022 | 820 | 0.550 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 4 | 2018 | 2282 | 0.530 |
Why?
|
| Testosterone | 11 | 2021 | 2470 | 0.520 |
Why?
|
| Folic Acid | 6 | 2019 | 1309 | 0.520 |
Why?
|
| Urine | 3 | 2015 | 363 | 0.510 |
Why?
|
| Growth | 2 | 2010 | 365 | 0.500 |
Why?
|
| Hormones | 3 | 2012 | 867 | 0.500 |
Why?
|
| Cohort Studies | 45 | 2022 | 41337 | 0.480 |
Why?
|
| Young Adult | 55 | 2021 | 58748 | 0.480 |
Why?
|
| Seafood | 5 | 2020 | 390 | 0.470 |
Why?
|
| o-Phthalaldehyde | 1 | 2014 | 15 | 0.470 |
Why?
|
| Fruit | 6 | 2021 | 1160 | 0.460 |
Why?
|
| Vegetables | 6 | 2021 | 1196 | 0.460 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2015 | 52 | 0.460 |
Why?
|
| Prediabetic State | 4 | 2021 | 550 | 0.460 |
Why?
|
| Pyridones | 4 | 2007 | 792 | 0.460 |
Why?
|
| Benzophenones | 4 | 2020 | 58 | 0.460 |
Why?
|
| Birth Weight | 6 | 2019 | 2097 | 0.460 |
Why?
|
| Massachusetts | 20 | 2020 | 8803 | 0.460 |
Why?
|
| Paper | 1 | 2014 | 85 | 0.460 |
Why?
|
| Premature Birth | 6 | 2021 | 1770 | 0.460 |
Why?
|
| Housing | 2 | 2018 | 665 | 0.450 |
Why?
|
| Benzofurans | 2 | 2011 | 142 | 0.440 |
Why?
|
| Ovulation Induction | 7 | 2020 | 277 | 0.440 |
Why?
|
| Adolescent | 55 | 2022 | 87809 | 0.430 |
Why?
|
| Antimony | 1 | 2012 | 19 | 0.430 |
Why?
|
| Food Preservatives | 1 | 2012 | 11 | 0.420 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2021 | 407 | 0.420 |
Why?
|
| Naphthalenes | 3 | 2014 | 198 | 0.420 |
Why?
|
| Dental Restoration, Permanent | 4 | 2014 | 128 | 0.410 |
Why?
|
| Disinfectants | 1 | 2014 | 130 | 0.410 |
Why?
|
| Boston | 18 | 2020 | 9278 | 0.400 |
Why?
|
| Ovary | 2 | 2013 | 958 | 0.400 |
Why?
|
| Genitalia, Male | 4 | 2019 | 87 | 0.390 |
Why?
|
| Marijuana Smoking | 3 | 2019 | 257 | 0.390 |
Why?
|
| Middle Aged | 84 | 2021 | 220359 | 0.390 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 4 | 2016 | 389 | 0.380 |
Why?
|
| Blood Glucose | 8 | 2021 | 6379 | 0.380 |
Why?
|
| Air Pollution | 6 | 2020 | 2317 | 0.380 |
Why?
|
| Cross-Sectional Studies | 33 | 2021 | 25941 | 0.370 |
Why?
|
| Herbicides | 2 | 2017 | 104 | 0.370 |
Why?
|
| Androgens | 4 | 2021 | 1291 | 0.360 |
Why?
|
| Carbanilides | 2 | 2021 | 18 | 0.360 |
Why?
|
| Child | 41 | 2022 | 79799 | 0.360 |
Why?
|
| Chromatography, High Pressure Liquid | 8 | 2018 | 1544 | 0.350 |
Why?
|
| Labor Onset | 1 | 2009 | 17 | 0.350 |
Why?
|
| Fishes | 4 | 2018 | 601 | 0.340 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2014 | 299 | 0.340 |
Why?
|
| MicroRNAs | 7 | 2021 | 3787 | 0.340 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2013 | 833 | 0.340 |
Why?
|
| Caprylates | 3 | 2019 | 113 | 0.340 |
Why?
|
| Diet | 15 | 2021 | 8010 | 0.340 |
Why?
|
| Pregnancy Trimester, First | 6 | 2022 | 908 | 0.340 |
Why?
|
| Trans Fatty Acids | 1 | 2010 | 155 | 0.330 |
Why?
|
| Puberty, Delayed | 1 | 2010 | 121 | 0.330 |
Why?
|
| Oocyte Retrieval | 5 | 2020 | 158 | 0.330 |
Why?
|
| Composite Resins | 3 | 2014 | 69 | 0.330 |
Why?
|
| Testicular Neoplasms | 3 | 2021 | 801 | 0.330 |
Why?
|
| Longitudinal Studies | 20 | 2021 | 14494 | 0.320 |
Why?
|
| Gestational Age | 7 | 2021 | 3564 | 0.320 |
Why?
|
| Child Development | 5 | 2021 | 2285 | 0.320 |
Why?
|
| Pharmaceutical Preparations | 3 | 2011 | 1091 | 0.320 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 237 | 0.310 |
Why?
|
| Models, Statistical | 3 | 2016 | 5075 | 0.310 |
Why?
|
| Cross-Over Studies | 8 | 2017 | 2061 | 0.310 |
Why?
|
| Cost of Illness | 2 | 2015 | 1940 | 0.310 |
Why?
|
| Air Pollutants, Occupational | 6 | 2008 | 407 | 0.310 |
Why?
|
| Diabetes, Gestational | 6 | 2022 | 1242 | 0.300 |
Why?
|
| Occupational Diseases | 6 | 2017 | 1486 | 0.300 |
Why?
|
| Fathers | 3 | 2019 | 376 | 0.300 |
Why?
|
| beta Carotene | 2 | 2019 | 524 | 0.300 |
Why?
|
| Hypersensitivity | 2 | 2017 | 1155 | 0.300 |
Why?
|
| Dairy Products | 3 | 2017 | 494 | 0.300 |
Why?
|
| Data Interpretation, Statistical | 4 | 2019 | 2696 | 0.300 |
Why?
|
| Preconception Care | 3 | 2019 | 139 | 0.290 |
Why?
|
| Isoflavones | 1 | 2008 | 136 | 0.290 |
Why?
|
| Particulate Matter | 8 | 2021 | 2559 | 0.290 |
Why?
|
| Lead Poisoning | 1 | 2010 | 321 | 0.290 |
Why?
|
| Benzoates | 1 | 2009 | 212 | 0.290 |
Why?
|
| Regression Analysis | 12 | 2017 | 6359 | 0.290 |
Why?
|
| Thyroxine | 2 | 2008 | 667 | 0.280 |
Why?
|
| Water Pollutants, Chemical | 3 | 2017 | 354 | 0.280 |
Why?
|
| Eating | 4 | 2018 | 1539 | 0.270 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 1928 | 0.270 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2006 | 28 | 0.270 |
Why?
|
| Food Contamination | 3 | 2019 | 192 | 0.270 |
Why?
|
| Urban Population | 2 | 2016 | 2022 | 0.270 |
Why?
|
| Granulosa Cells | 2 | 2019 | 115 | 0.270 |
Why?
|
| Andrology | 2 | 2005 | 11 | 0.270 |
Why?
|
| Hand Injuries | 6 | 2005 | 239 | 0.260 |
Why?
|
| Cryptorchidism | 2 | 2018 | 151 | 0.260 |
Why?
|
| Seasons | 3 | 2020 | 1522 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2021 | 12289 | 0.250 |
Why?
|
| RNA | 4 | 2019 | 2723 | 0.250 |
Why?
|
| Environmental Health | 1 | 2008 | 284 | 0.250 |
Why?
|
| Glucose Intolerance | 2 | 2022 | 580 | 0.250 |
Why?
|
| Chemical Industry | 1 | 2005 | 115 | 0.250 |
Why?
|
| Tandem Mass Spectrometry | 5 | 2018 | 1189 | 0.250 |
Why?
|
| Inhalation Exposure | 6 | 2008 | 429 | 0.240 |
Why?
|
| Plastics | 2 | 2017 | 115 | 0.240 |
Why?
|
| Accidents, Occupational | 5 | 2010 | 249 | 0.240 |
Why?
|
| Body Weight | 6 | 2018 | 4611 | 0.240 |
Why?
|
| Arsenic | 2 | 2017 | 357 | 0.230 |
Why?
|
| Pit and Fissure Sealants | 2 | 2014 | 27 | 0.230 |
Why?
|
| Embryo Transfer | 5 | 2020 | 522 | 0.230 |
Why?
|
| Age Factors | 11 | 2020 | 18413 | 0.220 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2007 | 812 | 0.220 |
Why?
|
| Household Products | 2 | 2019 | 27 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 5 | 2021 | 2005 | 0.220 |
Why?
|
| Dietary Supplements | 7 | 2019 | 3392 | 0.220 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 494 | 0.220 |
Why?
|
| Multivariate Analysis | 10 | 2019 | 12159 | 0.220 |
Why?
|
| Fertilization | 4 | 2019 | 197 | 0.210 |
Why?
|
| Sperm Injections, Intracytoplasmic | 4 | 2019 | 156 | 0.210 |
Why?
|
| Pollen | 1 | 2003 | 81 | 0.210 |
Why?
|
| Pilot Projects | 8 | 2019 | 8556 | 0.210 |
Why?
|
| Infant, Newborn | 20 | 2021 | 26179 | 0.210 |
Why?
|
| Thyrotropin | 3 | 2020 | 832 | 0.210 |
Why?
|
| Equipment and Supplies | 3 | 2013 | 275 | 0.210 |
Why?
|
| Feeding Behavior | 4 | 2018 | 3185 | 0.210 |
Why?
|
| Dietary Proteins | 2 | 2018 | 949 | 0.210 |
Why?
|
| Dental Amalgam | 2 | 2012 | 65 | 0.210 |
Why?
|
| Odds Ratio | 10 | 2021 | 9716 | 0.200 |
Why?
|
| Organophosphorus Compounds | 3 | 2016 | 202 | 0.200 |
Why?
|
| Women's Health | 4 | 2021 | 2056 | 0.200 |
Why?
|
| Oogenesis | 2 | 2019 | 124 | 0.200 |
Why?
|
| Gloves, Protective | 3 | 2014 | 23 | 0.200 |
Why?
|
| Reproductive Techniques | 1 | 2021 | 41 | 0.190 |
Why?
|
| Bronchitis | 1 | 2002 | 196 | 0.190 |
Why?
|
| Life Style | 7 | 2021 | 3898 | 0.190 |
Why?
|
| Reference Values | 5 | 2014 | 4925 | 0.190 |
Why?
|
| Stillbirth | 2 | 2014 | 367 | 0.190 |
Why?
|
| Nitrogen Dioxide | 3 | 2020 | 512 | 0.190 |
Why?
|
| Self Report | 6 | 2019 | 3711 | 0.190 |
Why?
|
| Body Height | 3 | 2017 | 1570 | 0.190 |
Why?
|
| Aromatase | 2 | 2013 | 147 | 0.190 |
Why?
|
| Obesity | 9 | 2021 | 12919 | 0.190 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2002 | 302 | 0.190 |
Why?
|
| Risk Factors | 31 | 2021 | 74333 | 0.180 |
Why?
|
| Biotransformation | 2 | 2012 | 166 | 0.180 |
Why?
|
| Weight Loss | 1 | 2012 | 2684 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2019 | 10826 | 0.180 |
Why?
|
| Logistic Models | 11 | 2020 | 13312 | 0.180 |
Why?
|
| Omeprazole | 2 | 2013 | 112 | 0.180 |
Why?
|
| Sulfones | 2 | 2021 | 447 | 0.180 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2014 | 389 | 0.180 |
Why?
|
| Metals | 4 | 2008 | 736 | 0.180 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2003 | 345 | 0.170 |
Why?
|
| Body Composition | 2 | 2019 | 2419 | 0.170 |
Why?
|
| Toxicity Tests | 2 | 2019 | 111 | 0.170 |
Why?
|
| Meat | 2 | 2015 | 584 | 0.170 |
Why?
|
| Cadmium | 2 | 2013 | 215 | 0.170 |
Why?
|
| Perimenopause | 1 | 2021 | 141 | 0.170 |
Why?
|
| Dicarboxylic Acids | 2 | 2018 | 77 | 0.170 |
Why?
|
| Risk Assessment | 15 | 2021 | 24102 | 0.170 |
Why?
|
| Time Factors | 18 | 2019 | 40139 | 0.170 |
Why?
|
| Michigan | 4 | 2021 | 342 | 0.170 |
Why?
|
| Soaps | 1 | 2019 | 29 | 0.170 |
Why?
|
| Pregnancy Trimester, Second | 6 | 2020 | 732 | 0.170 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2019 | 29 | 0.170 |
Why?
|
| Reproductive Medicine | 2 | 2019 | 100 | 0.160 |
Why?
|
| Infant, Premature | 1 | 2008 | 2092 | 0.160 |
Why?
|
| Electromagnetic Fields | 1 | 2020 | 296 | 0.160 |
Why?
|
| Placenta | 3 | 2016 | 1702 | 0.160 |
Why?
|
| Sunscreening Agents | 1 | 2019 | 139 | 0.150 |
Why?
|
| Ozone | 2 | 2020 | 477 | 0.150 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2019 | 463 | 0.150 |
Why?
|
| Hot Flashes | 1 | 2021 | 328 | 0.150 |
Why?
|
| Lacerations | 3 | 2010 | 148 | 0.150 |
Why?
|
| Uterine Neoplasms | 2 | 2021 | 1439 | 0.150 |
Why?
|
| Hypospadias | 1 | 2018 | 98 | 0.140 |
Why?
|
| Particle Size | 11 | 2008 | 1644 | 0.140 |
Why?
|
| Bayes Theorem | 6 | 2021 | 2326 | 0.140 |
Why?
|
| Prolactin | 2 | 2010 | 621 | 0.140 |
Why?
|
| Breast Feeding | 3 | 2019 | 1355 | 0.140 |
Why?
|
| Polypropylenes | 1 | 2017 | 63 | 0.140 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 297 | 0.140 |
Why?
|
| Policy Making | 1 | 2021 | 538 | 0.140 |
Why?
|
| Dietary Fats | 3 | 2016 | 1992 | 0.140 |
Why?
|
| Osmolar Concentration | 2 | 2010 | 660 | 0.140 |
Why?
|
| Spermatogenesis | 4 | 2019 | 257 | 0.140 |
Why?
|
| Glass | 1 | 2017 | 115 | 0.140 |
Why?
|
| Military Personnel | 1 | 2006 | 1244 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2018 | 363 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2011 | 14661 | 0.140 |
Why?
|
| Spectrophotometry, Atomic | 2 | 2013 | 82 | 0.140 |
Why?
|
| Diet Surveys | 5 | 2019 | 1161 | 0.140 |
Why?
|
| Pregnancy Complications | 3 | 2020 | 2942 | 0.140 |
Why?
|
| Lifting | 1 | 2017 | 55 | 0.140 |
Why?
|
| Animals | 29 | 2021 | 167960 | 0.140 |
Why?
|
| Bisphenol A-Glycidyl Methacrylate | 2 | 2014 | 15 | 0.130 |
Why?
|
| Food Handling | 3 | 2015 | 155 | 0.130 |
Why?
|
| Spouses | 1 | 2018 | 279 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 655 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2019 | 515 | 0.130 |
Why?
|
| Marriage | 1 | 2017 | 350 | 0.130 |
Why?
|
| Carbon Monoxide | 2 | 2016 | 541 | 0.130 |
Why?
|
| Blastocyst | 1 | 2019 | 433 | 0.130 |
Why?
|
| Milk, Human | 2 | 2014 | 483 | 0.130 |
Why?
|
| Confidence Intervals | 3 | 2014 | 2932 | 0.130 |
Why?
|
| Obesity, Abdominal | 1 | 2019 | 374 | 0.130 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2016 | 140 | 0.130 |
Why?
|
| Asthma | 4 | 2013 | 6172 | 0.130 |
Why?
|
| Fuel Oils | 2 | 2005 | 35 | 0.130 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 2015 | 17 | 0.130 |
Why?
|
| Rural Health | 1 | 2017 | 296 | 0.130 |
Why?
|
| Infant Equipment | 1 | 2015 | 23 | 0.130 |
Why?
|
| Pectinidae | 1 | 2015 | 5 | 0.130 |
Why?
|
| Allergens | 1 | 2003 | 1402 | 0.130 |
Why?
|
| Triiodothyronine | 2 | 2008 | 493 | 0.120 |
Why?
|
| Electric Impedance | 1 | 2019 | 755 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 4 | 2017 | 926 | 0.120 |
Why?
|
| Eunuchism | 1 | 2015 | 19 | 0.120 |
Why?
|
| Feminine Hygiene Products | 1 | 2014 | 3 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2020 | 665 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2019 | 926 | 0.120 |
Why?
|
| Construction Materials | 2 | 2007 | 60 | 0.120 |
Why?
|
| Endocrine System Diseases | 2 | 2015 | 250 | 0.120 |
Why?
|
| Pregnancy Trimesters | 1 | 2016 | 197 | 0.120 |
Why?
|
| Academic Medical Centers | 6 | 2019 | 2754 | 0.120 |
Why?
|
| Play and Playthings | 1 | 2015 | 83 | 0.120 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 2421 | 0.120 |
Why?
|
| Consumer Product Safety | 1 | 2015 | 123 | 0.120 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antioxidants | 2 | 2019 | 1667 | 0.120 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 151 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 685 | 0.120 |
Why?
|
| Epidemiologic Studies | 3 | 2018 | 670 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2018 | 7805 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39262 | 0.110 |
Why?
|
| Meat Products | 1 | 2014 | 96 | 0.110 |
Why?
|
| Heart Rate | 4 | 2008 | 4180 | 0.110 |
Why?
|
| Occupations | 3 | 2005 | 515 | 0.110 |
Why?
|
| Semen Preservation | 1 | 2013 | 35 | 0.110 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2362 | 0.110 |
Why?
|
| Thyroid Gland | 1 | 2020 | 1168 | 0.110 |
Why?
|
| Dental Materials | 1 | 2014 | 113 | 0.110 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2011 | 352 | 0.110 |
Why?
|
| Sex Factors | 5 | 2021 | 10546 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2019 | 3959 | 0.110 |
Why?
|
| Cannabis | 1 | 2019 | 436 | 0.110 |
Why?
|
| Endpoint Determination | 3 | 2015 | 597 | 0.110 |
Why?
|
| Menopause | 1 | 2021 | 1640 | 0.110 |
Why?
|
| Work Schedule Tolerance | 1 | 2017 | 551 | 0.100 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 20080 | 0.100 |
Why?
|
| Luminescence | 1 | 2013 | 133 | 0.100 |
Why?
|
| Resin Cements | 1 | 2012 | 31 | 0.100 |
Why?
|
| Amitriptyline | 1 | 2013 | 112 | 0.100 |
Why?
|
| Fetus | 1 | 2020 | 1859 | 0.100 |
Why?
|
| Cardiovascular Diseases | 5 | 2021 | 15760 | 0.100 |
Why?
|
| Polyethylene Terephthalates | 1 | 2012 | 115 | 0.100 |
Why?
|
| Rats | 8 | 2019 | 23709 | 0.100 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 211 | 0.100 |
Why?
|
| Body Size | 2 | 2018 | 462 | 0.100 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 522 | 0.100 |
Why?
|
| Exercise | 3 | 2020 | 5787 | 0.100 |
Why?
|
| Methacrylates | 1 | 2012 | 109 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2011 | 12531 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2019 | 484 | 0.100 |
Why?
|
| DDT | 1 | 2011 | 31 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2021 | 1387 | 0.100 |
Why?
|
| Polyurethanes | 1 | 2012 | 108 | 0.100 |
Why?
|
| Power Plants | 4 | 2005 | 123 | 0.100 |
Why?
|
| Carbidopa | 1 | 2011 | 30 | 0.100 |
Why?
|
| Excipients | 1 | 2011 | 97 | 0.100 |
Why?
|
| Body Burden | 2 | 2019 | 158 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2019 | 1334 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 7593 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 203 | 0.100 |
Why?
|
| Infant Formula | 1 | 2013 | 193 | 0.100 |
Why?
|
| Learning | 2 | 2018 | 1739 | 0.090 |
Why?
|
| Child Behavior | 2 | 2014 | 847 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 378 | 0.090 |
Why?
|
| Geography | 1 | 2013 | 661 | 0.090 |
Why?
|
| Body Weights and Measures | 2 | 2008 | 208 | 0.090 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 892 | 0.090 |
Why?
|
| Memory | 2 | 2018 | 2179 | 0.090 |
Why?
|
| Astrocytes | 1 | 2019 | 1337 | 0.090 |
Why?
|
| Food-Processing Industry | 1 | 2010 | 14 | 0.090 |
Why?
|
| Occupational Health | 3 | 2008 | 806 | 0.090 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2012 | 296 | 0.090 |
Why?
|
| Nonprescription Drugs | 1 | 2011 | 118 | 0.090 |
Why?
|
| New York City | 2 | 2010 | 724 | 0.090 |
Why?
|
| Aging | 3 | 2017 | 8652 | 0.090 |
Why?
|
| Levodopa | 1 | 2011 | 217 | 0.090 |
Why?
|
| Milk | 1 | 2013 | 443 | 0.090 |
Why?
|
| Compulsive Behavior | 1 | 2011 | 117 | 0.090 |
Why?
|
| Oligospermia | 1 | 2010 | 59 | 0.090 |
Why?
|
| Culture Media | 1 | 2012 | 900 | 0.090 |
Why?
|
| Antiparkinson Agents | 1 | 2011 | 183 | 0.090 |
Why?
|
| Mothers | 1 | 2021 | 2186 | 0.090 |
Why?
|
| Nitric Oxide | 3 | 2003 | 2141 | 0.090 |
Why?
|
| Dominican Republic | 1 | 2009 | 74 | 0.090 |
Why?
|
| Organ Size | 2 | 2013 | 2254 | 0.090 |
Why?
|
| Cadmium Poisoning | 1 | 2009 | 11 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2018 | 2119 | 0.090 |
Why?
|
| Fetal Mortality | 1 | 2009 | 19 | 0.090 |
Why?
|
| Social Adjustment | 1 | 2012 | 632 | 0.090 |
Why?
|
| Treatment Outcome | 14 | 2021 | 64981 | 0.090 |
Why?
|
| Incidence | 8 | 2021 | 21391 | 0.080 |
Why?
|
| Carbon | 2 | 2003 | 669 | 0.080 |
Why?
|
| Affective Symptoms | 1 | 2012 | 416 | 0.080 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 87 | 0.080 |
Why?
|
| Fires | 2 | 2008 | 169 | 0.080 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2009 | 25 | 0.080 |
Why?
|
| Protective Devices | 1 | 2009 | 72 | 0.080 |
Why?
|
| Anthropometry | 3 | 2019 | 1348 | 0.080 |
Why?
|
| Delusions | 1 | 2011 | 298 | 0.080 |
Why?
|
| Urinalysis | 2 | 2015 | 368 | 0.080 |
Why?
|
| Hair Preparations | 2 | 2010 | 32 | 0.080 |
Why?
|
| Vanadium | 2 | 2005 | 54 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3617 | 0.080 |
Why?
|
| Didanosine | 1 | 2008 | 151 | 0.080 |
Why?
|
| United States | 17 | 2021 | 72448 | 0.080 |
Why?
|
| Climate Change | 1 | 2015 | 488 | 0.080 |
Why?
|
| Theophylline | 1 | 2008 | 131 | 0.080 |
Why?
|
| Commerce | 1 | 2014 | 605 | 0.080 |
Why?
|
| Hand | 1 | 2014 | 903 | 0.080 |
Why?
|
| Hallucinations | 1 | 2011 | 366 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2011 | 956 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1858 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 580 | 0.080 |
Why?
|
| Smoking | 5 | 2019 | 9073 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2852 | 0.080 |
Why?
|
| Beauty Culture | 1 | 2008 | 41 | 0.080 |
Why?
|
| Trophoblasts | 1 | 2010 | 224 | 0.080 |
Why?
|
| Attention | 1 | 2018 | 2387 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 15790 | 0.080 |
Why?
|
| Welding | 2 | 2005 | 89 | 0.080 |
Why?
|
| Lipids | 1 | 2019 | 3336 | 0.080 |
Why?
|
| Rescue Work | 1 | 2008 | 56 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2019 | 12762 | 0.070 |
Why?
|
| Endocrine System | 1 | 2008 | 112 | 0.070 |
Why?
|
| Family Characteristics | 3 | 2018 | 1001 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 981 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 1557 | 0.070 |
Why?
|
| Fetal Development | 1 | 2013 | 766 | 0.070 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 805 | 0.070 |
Why?
|
| Israel | 2 | 2021 | 722 | 0.070 |
Why?
|
| Child Welfare | 1 | 2011 | 516 | 0.070 |
Why?
|
| Immunoassay | 2 | 2008 | 746 | 0.070 |
Why?
|
| Amniotic Fluid | 2 | 2007 | 378 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2013 | 1195 | 0.070 |
Why?
|
| Birth Rate | 2 | 2019 | 168 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2009 | 236 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 1674 | 0.070 |
Why?
|
| Overweight | 2 | 2021 | 2421 | 0.070 |
Why?
|
| New England | 4 | 2020 | 1050 | 0.070 |
Why?
|
| Weight Gain | 1 | 2016 | 2347 | 0.070 |
Why?
|
| Metallurgy | 4 | 2008 | 95 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2020 | 8525 | 0.070 |
Why?
|
| Estrogens | 1 | 2013 | 1520 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 854 | 0.070 |
Why?
|
| Risk Management | 1 | 2009 | 558 | 0.060 |
Why?
|
| Educational Status | 1 | 2013 | 2514 | 0.060 |
Why?
|
| Hydrocarbons | 1 | 2006 | 105 | 0.060 |
Why?
|
| Health Surveys | 3 | 2013 | 4063 | 0.060 |
Why?
|
| Meat-Packing Industry | 1 | 2005 | 12 | 0.060 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 321 | 0.060 |
Why?
|
| Bangladesh | 2 | 2017 | 728 | 0.060 |
Why?
|
| Infant | 7 | 2021 | 36053 | 0.060 |
Why?
|
| Cognition | 2 | 2013 | 6964 | 0.060 |
Why?
|
| Endometrium | 2 | 2019 | 403 | 0.060 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2020 | 582 | 0.060 |
Why?
|
| Sperm Tail | 1 | 2004 | 15 | 0.060 |
Why?
|
| Gonadotropins | 2 | 2016 | 241 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2019 | 5991 | 0.060 |
Why?
|
| Steroids | 1 | 2010 | 928 | 0.060 |
Why?
|
| Industry | 2 | 2003 | 361 | 0.060 |
Why?
|
| Meiosis | 2 | 2019 | 328 | 0.060 |
Why?
|
| Prescription Drugs | 1 | 2011 | 630 | 0.060 |
Why?
|
| Hygiene | 1 | 2004 | 94 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2013 | 1504 | 0.060 |
Why?
|
| Cooking | 2 | 2016 | 311 | 0.060 |
Why?
|
| Motor Activity | 1 | 2014 | 2688 | 0.060 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2003 | 77 | 0.060 |
Why?
|
| Pregnant Women | 2 | 2020 | 563 | 0.060 |
Why?
|
| Incineration | 1 | 2003 | 21 | 0.060 |
Why?
|
| Trauma Severity Indices | 2 | 2002 | 478 | 0.060 |
Why?
|
| Refuse Disposal | 1 | 2003 | 31 | 0.050 |
Why?
|
| Ontario | 2 | 2014 | 404 | 0.050 |
Why?
|
| Pyrenes | 1 | 2003 | 48 | 0.050 |
Why?
|
| Selection Bias | 1 | 2005 | 358 | 0.050 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 220 | 0.050 |
Why?
|
| Mental Recall | 1 | 2009 | 1206 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2004 | 276 | 0.050 |
Why?
|
| Heating | 1 | 2003 | 101 | 0.050 |
Why?
|
| Population | 1 | 2003 | 140 | 0.050 |
Why?
|
| Algorithms | 3 | 2019 | 13982 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9406 | 0.050 |
Why?
|
| Data Collection | 2 | 2009 | 3315 | 0.050 |
Why?
|
| Quality Control | 1 | 2005 | 828 | 0.050 |
Why?
|
| Retrospective Studies | 9 | 2021 | 80345 | 0.050 |
Why?
|
| Cities | 2 | 2019 | 538 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2003 | 150 | 0.050 |
Why?
|
| Task Performance and Analysis | 2 | 2009 | 759 | 0.050 |
Why?
|
| Safety Management | 1 | 2008 | 760 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2021 | 42056 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12628 | 0.050 |
Why?
|
| Zinc | 2 | 2003 | 689 | 0.050 |
Why?
|
| Beta Particles | 1 | 2021 | 47 | 0.050 |
Why?
|
| Endometriosis | 1 | 2010 | 874 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 727 | 0.050 |
Why?
|
| Aged | 13 | 2019 | 169143 | 0.050 |
Why?
|
| Tanzania | 2 | 2016 | 1383 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3802 | 0.050 |
Why?
|
| Phenol | 1 | 2021 | 44 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 1752 | 0.050 |
Why?
|
| Silicones | 1 | 2021 | 227 | 0.040 |
Why?
|
| Research Design | 2 | 2019 | 6180 | 0.040 |
Why?
|
| Case-Control Studies | 5 | 2011 | 22052 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 2222 | 0.040 |
Why?
|
| Demography | 1 | 2005 | 1650 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8552 | 0.040 |
Why?
|
| Skin Tests | 1 | 2002 | 637 | 0.040 |
Why?
|
| Diet, Mediterranean | 2 | 2019 | 735 | 0.040 |
Why?
|
| Parents | 2 | 2019 | 3549 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5201 | 0.040 |
Why?
|
| Respiratory System | 1 | 2003 | 557 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 211 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2004 | 707 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 81 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17790 | 0.040 |
Why?
|
| Linuron | 1 | 2019 | 4 | 0.040 |
Why?
|
| Creatinine | 1 | 2005 | 1904 | 0.040 |
Why?
|
| Luciferases | 1 | 2021 | 716 | 0.040 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 74 | 0.040 |
Why?
|
| Spirometry | 1 | 2002 | 924 | 0.040 |
Why?
|
| Poly A | 1 | 2019 | 181 | 0.040 |
Why?
|
| Weights and Measures | 1 | 2018 | 41 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2004 | 838 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 708 | 0.040 |
Why?
|
| Denmark | 1 | 2021 | 760 | 0.040 |
Why?
|
| Receptors, sigma | 1 | 2019 | 45 | 0.040 |
Why?
|
| Rats, Inbred WKY | 3 | 2003 | 151 | 0.040 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 294 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2016 | 6238 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2005 | 1343 | 0.040 |
Why?
|
| Women | 1 | 2020 | 225 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2011 | 10185 | 0.040 |
Why?
|
| Gene Library | 1 | 2021 | 1060 | 0.040 |
Why?
|
| Risk | 3 | 2019 | 9632 | 0.040 |
Why?
|
| Sweden | 1 | 2021 | 1381 | 0.040 |
Why?
|
| Cholesterol | 2 | 2019 | 2924 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2019 | 3604 | 0.040 |
Why?
|
| Consensus | 1 | 2007 | 3113 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 2192 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2019 | 229 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2002 | 1809 | 0.040 |
Why?
|
| Models, Theoretical | 2 | 2019 | 3562 | 0.040 |
Why?
|
| Workplace | 1 | 2003 | 858 | 0.040 |
Why?
|
| Chromosomes, Human, X | 1 | 2019 | 321 | 0.040 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 697 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 783 | 0.030 |
Why?
|
| X Chromosome Inactivation | 1 | 2019 | 226 | 0.030 |
Why?
|
| Netherlands | 2 | 2014 | 2213 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 854 | 0.030 |
Why?
|
| Government Regulation | 1 | 2021 | 525 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 1376 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2021 | 1996 | 0.030 |
Why?
|
| Progesterone | 1 | 2020 | 742 | 0.030 |
Why?
|
| Medical Records | 2 | 2017 | 1407 | 0.030 |
Why?
|
| Patient Participation | 1 | 2005 | 1439 | 0.030 |
Why?
|
| Ghana | 1 | 2017 | 312 | 0.030 |
Why?
|
| Public Health | 1 | 2009 | 2653 | 0.030 |
Why?
|
| Phytoestrogens | 1 | 2016 | 59 | 0.030 |
Why?
|
| Arteries | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Ecosystem | 1 | 2020 | 485 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 15286 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2017 | 507 | 0.030 |
Why?
|
| Lung | 3 | 2003 | 9994 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1174 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 784 | 0.030 |
Why?
|
| Poultry | 1 | 2015 | 81 | 0.030 |
Why?
|
| Administration, Inhalation | 3 | 2003 | 1156 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1895 | 0.030 |
Why?
|
| Myocarditis | 1 | 2003 | 766 | 0.030 |
Why?
|
| Premenopause | 1 | 2019 | 1038 | 0.030 |
Why?
|
| Microvessels | 1 | 2019 | 572 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2019 | 753 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 982 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 939 | 0.030 |
Why?
|
| Shellfish | 1 | 2014 | 37 | 0.030 |
Why?
|
| Diet Records | 1 | 2016 | 427 | 0.030 |
Why?
|
| Smoke | 1 | 2016 | 236 | 0.030 |
Why?
|
| Compomers | 1 | 2014 | 6 | 0.030 |
Why?
|
| Child Care | 1 | 2015 | 121 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2019 | 716 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 26951 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 992 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 824 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 5890 | 0.030 |
Why?
|
| Probability | 1 | 2019 | 2475 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2019 | 1736 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 807 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 579 | 0.030 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 825 | 0.030 |
Why?
|
| Zirconium | 1 | 2014 | 107 | 0.030 |
Why?
|
| Inflammation | 3 | 2019 | 10755 | 0.030 |
Why?
|
| Ectogenesis | 1 | 2012 | 8 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2389 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 4626 | 0.030 |
Why?
|
| Genomics | 2 | 2019 | 5795 | 0.030 |
Why?
|
| Rats, Inbred SHR | 2 | 2003 | 186 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 216 | 0.030 |
Why?
|
| Intelligence Tests | 1 | 2014 | 498 | 0.030 |
Why?
|
| Environment | 1 | 2019 | 1118 | 0.030 |
Why?
|
| Polybrominated Biphenyls | 1 | 2012 | 25 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 859 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 1741 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2008 | 578 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 226 | 0.030 |
Why?
|
| RNA, Small Untranslated | 1 | 2013 | 77 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2014 | 243 | 0.030 |
Why?
|
| Breath Tests | 2 | 2003 | 297 | 0.030 |
Why?
|
| Prevalence | 3 | 2019 | 15686 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2020 | 1370 | 0.020 |
Why?
|
| Polyadenylation | 1 | 2013 | 117 | 0.020 |
Why?
|
| Taiwan | 1 | 2013 | 505 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2004 | 1919 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2013 | 212 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 10343 | 0.020 |
Why?
|
| Limit of Detection | 1 | 2012 | 280 | 0.020 |
Why?
|
| North America | 1 | 2015 | 1284 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 330 | 0.020 |
Why?
|
| Suction | 1 | 2012 | 263 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 267 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2015 | 795 | 0.020 |
Why?
|
| Age Distribution | 1 | 2017 | 2893 | 0.020 |
Why?
|
| Nebraska | 1 | 2010 | 32 | 0.020 |
Why?
|
| Workload | 1 | 2017 | 847 | 0.020 |
Why?
|
| Menarche | 1 | 2014 | 529 | 0.020 |
Why?
|
| RNA Stability | 1 | 2013 | 333 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1088 | 0.020 |
Why?
|
| Deodorants | 1 | 2010 | 3 | 0.020 |
Why?
|
| Mice | 4 | 2019 | 81209 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1739 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2003 | 9288 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2002 | 748 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 575 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2012 | 650 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2012 | 462 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 7022 | 0.020 |
Why?
|
| Myocardium | 1 | 2003 | 4700 | 0.020 |
Why?
|
| Ohio | 1 | 2010 | 333 | 0.020 |
Why?
|
| Albumins | 2 | 2002 | 577 | 0.020 |
Why?
|
| Testis | 1 | 2013 | 794 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2009 | 47 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2009 | 57 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 211 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3465 | 0.020 |
Why?
|
| Breech Presentation | 1 | 2009 | 39 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 1683 | 0.020 |
Why?
|
| Insect Control | 1 | 2008 | 29 | 0.020 |
Why?
|
| Gene Expression | 2 | 2013 | 7587 | 0.020 |
Why?
|
| Cockroaches | 1 | 2008 | 97 | 0.020 |
Why?
|
| Species Specificity | 2 | 2003 | 2418 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3106 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3441 | 0.020 |
Why?
|
| Manufactured Materials | 1 | 2007 | 17 | 0.020 |
Why?
|
| Cytokines | 1 | 2003 | 7344 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2011 | 961 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2008 | 103 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11481 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 1720 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2019 | 3300 | 0.020 |
Why?
|
| Ventilation | 1 | 2008 | 128 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2014 | 1168 | 0.020 |
Why?
|
| Animals, Wild | 1 | 2007 | 77 | 0.020 |
Why?
|
| Genitalia, Female | 1 | 2008 | 147 | 0.020 |
Why?
|
| Zebrafish | 1 | 2019 | 2997 | 0.020 |
Why?
|
| Chromatin | 1 | 2019 | 2938 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 361 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 2007 | 139 | 0.020 |
Why?
|
| North Carolina | 1 | 2007 | 325 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12957 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3505 | 0.020 |
Why?
|
| Triglycerides | 1 | 2014 | 2476 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2011 | 6415 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4899 | 0.020 |
Why?
|
| Leptin | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Reaction Time | 1 | 2013 | 2075 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 4013 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 978 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2126 | 0.020 |
Why?
|
| Threshold Limit Values | 1 | 2005 | 12 | 0.020 |
Why?
|
| Polyvinyl Chloride | 1 | 2005 | 32 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6218 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1664 | 0.020 |
Why?
|
| Hypertension | 2 | 2002 | 8595 | 0.020 |
Why?
|
| Alberta | 1 | 2005 | 66 | 0.020 |
Why?
|
| Respiratory Protective Devices | 1 | 2005 | 47 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1849 | 0.020 |
Why?
|
| Upper Extremity | 1 | 2010 | 661 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2005 | 68 | 0.020 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 2005 | 54 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2015 | 1214 | 0.020 |
Why?
|
| Maximum Allowable Concentration | 1 | 2005 | 63 | 0.020 |
Why?
|
| Kidney | 1 | 2021 | 7064 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21029 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 2025 | 0.020 |
Why?
|
| Hospitals | 1 | 2018 | 3928 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15620 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16932 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 8158 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2012 | 1804 | 0.010 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 18137 | 0.010 |
Why?
|
| Healthy Worker Effect | 1 | 2003 | 29 | 0.010 |
Why?
|
| Transition Elements | 1 | 2003 | 17 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 3204 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 791 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 5961 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 2003 | 216 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 18955 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2262 | 0.010 |
Why?
|
| Liver | 1 | 2019 | 7510 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2002 | 32 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2003 | 220 | 0.010 |
Why?
|
| Oils | 1 | 2002 | 56 | 0.010 |
Why?
|
| Causality | 1 | 2009 | 1242 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2647 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2009 | 2659 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4571 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2019 | 23374 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2002 | 398 | 0.010 |
Why?
|
| Motor Vehicles | 1 | 2003 | 281 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2005 | 624 | 0.010 |
Why?
|
| Occupational Health Services | 1 | 2002 | 150 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 6015 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29661 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2117 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4775 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 58980 | 0.010 |
Why?
|
| Swine | 1 | 2010 | 5899 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 2003 | 409 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1826 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22020 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6065 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 284 | 0.010 |
Why?
|
| Laboratories | 1 | 2004 | 462 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2009 | 1385 | 0.010 |
Why?
|
| Aerosols | 1 | 2002 | 632 | 0.010 |
Why?
|
| Insulin | 1 | 2014 | 6596 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2009 | 2314 | 0.010 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2015 | 3701 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3759 | 0.010 |
Why?
|
| Breast | 1 | 2008 | 1963 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1148 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2002 | 887 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2003 | 1089 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2629 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1440 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2011 | 2859 | 0.010 |
Why?
|
| Respiration | 1 | 2003 | 1654 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 2570 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15840 | 0.010 |
Why?
|
| Fibrosis | 1 | 2003 | 2042 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 3520 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5869 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2003 | 1915 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 7268 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2008 | 3426 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4446 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2004 | 2041 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 11902 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 3767 | 0.010 |
Why?
|
| Heart | 1 | 2003 | 4393 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2002 | 2809 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 9497 | 0.000 |
Why?
|
| Neoplasms | 1 | 2009 | 22075 | 0.000 |
Why?
|